Cervical Spondylosis Diagnosis & Treatment Market Size is valued at USD 6.19 Bn in 2023 and is predicted to reach USD 10.14 Bn by the year 2031 at a 6.3% CAGR during the forecast period for 2024-2031.
Cervical spondylosis is a degenerative disorder that affects the neck region and is treated with therapy. These therapies reduce discomfort, boost mobility, and forestall nerve and spinal cord degeneration. Pain and stiffness can be experienced due to cervical spondylosis, which occurs when the bones and discs in the neck become compressed. More effective therapies are now possible because of better surgical techniques, such as spinal implants. With these implants, the spine can be supported, and nerve pressure can be reduced. The improved accuracy of modern surgical techniques has allowed for safer, shorter patient recovery times. As a result, the market for cervical spondylosis diagnosis and therapy has grown substantially. Patients profit from enhanced surgical alternatives, which lead to less discomfort and greater mobility. Globally, more and more people are becoming aware of cervical spondylosis, which is driving the market expansion. Researchers and innovators work tirelessly to push the field forward, which bodes well for future improvements.
However, market growth is hampered by the lack of safety awareness criteria. Getting diagnosed and treated helps prevent the problem from getting worse over time. If people wait until cervical spondylosis has worsened before seeing a doctor and receiving treatment, the condition will be more difficult to control and may cause further issues.
The cervical spondylosis diagnosis & treatment market is segmented based on diagnosis, product type, and distribution channel. Based on diagnosis, the market inlcludes imaging tests, neck X-ray, MRI, CT myelography, nerve function tests, electromyography, and nerve conduction study. As per the product type, the market is segmented into Medications (Non-steroidal Anti-Inflammatory Drugs, Muscle Relaxants, Antidepressants, Pain Relievers), Medical Devices (Cervical Collars, Neck Traction Devices, TENS Units, Cervical Pillows), and Surgical Instruments (Spinal Implants, Other Surgical Instruments). The distribution channel segment is segmented into hospital pharmacies, retail pharmacies, and online pharmacies.
The retail pharmacies' cervical spondylosis diagnosis and treatment market is expected to lead with a major global market share. Retail pharmacists dispense pharmaceuticals and medical supplies to the general public and other healthcare professionals, as well as a wide variety of personal care items, art supplies, photography equipment, and pet supplies.
The medications industry makes up the bulk of acrylic acid ester usage because the medications help reduce inflammation and improve symptoms of cervical spondylosis. Medications are substances used to diagnose, prevent, treat, or manage numerous medical disorders and diseases, especially in countries like the US, Germany, the UK, China, and India.
The North American cervical spondylosis diagnosis & treatment market is expected to record a large market share in revenue in the near future. This can be caused due to the high healthcare expenditure and infrastructure development. In addition, Asia Pacific is prdicted to grow rapidly in the global cervical spondylosis diagnosis & treatment market because large populations, growing urbanization, higher levels of education and awareness of respiratory disorders, and better healthcare infrastructure are all driving forces behind this expansion.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 6.19 Bn |
|
Revenue Forecast In 2031 |
USD 10.14 Bn |
|
Growth Rate CAGR |
CAGR of 6.3% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Diagnosis, Product Type, Distribution Channel |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; Southeast Asia; South Korea |
|
Competitive Landscape |
Novartis AG, Merck & Co. Inc., Bayer AG, Abbott, Ortho Bracing, Medtronic, Stryker Corporation, B. Braun Medical Ltd., DJO, LLC, Aspen Medical Products, LLC., Bristol-Myers Squibb Company, Eli Lilly and Company, AstraZeneca Plc., Pfizer, Teva Pharmaceutical Industries Ltd., and GlaxoSmithKline plc. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Cervical Spondylosis Diagnosis & Treatment Market Snapshot
Chapter 4. Global Cervical Spondylosis Diagnosis & Treatment Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Diagnosis Estimates & Trend Analysis
5.1. by Diagnosis & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Diagnosis:
5.2.1. Imaging Tests
5.2.2. Neck X-ray
5.2.3. MRI
5.2.4. CT Myelography
5.2.5. Nerve Function Tests
5.2.6. Electromyography
5.2.7. Nerve Conduction Study
Chapter 6. Market Segmentation 2: by Product Type Estimates & Trend Analysis
6.1. by Product Type & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Product Type:
6.2.1. Medications
6.2.1.1. Non-steroidal AntiInflammatory Drugs
6.2.1.2. Muscle Relaxants
6.2.1.3. Antidepressants
6.2.1.4. Pain Relievers
6.2.2. Medical Devices
6.2.2.1. Cervical Collars
6.2.2.2. Neck Traction Devices
6.2.2.3. TENS Units
6.2.2.4. Cervical Pillows
6.2.3. Surgical Instruments
6.2.3.1. Spinal Implants
6.2.3.2. Other Surgical Instruments
Chapter 7. Market Segmentation 3: by Distribution Channel Estimates & Trend Analysis
7.1. by Distribution Channel & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Distribution Channel:
7.2.1. Hospital Pharmacies
7.2.2. Retail Pharmacies
7.2.3. Online Pharmacies
Chapter 8. Cervical Spondylosis Diagnosis & Treatment Market Segmentation 6: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by Diagnosis, 2019-2031
8.1.2. North America Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2019-2031
8.1.3. North America Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2019-2031
8.1.4. North America Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.2. Europe
8.2.1. Europe Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by Diagnosis, 2019-2031
8.2.2. Europe Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2019-2031
8.2.3. Europe Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2019-2031
8.2.4. Europe Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by Diagnosis, 2019-2031
8.3.2. Asia Pacific Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2019-2031
8.3.3. Asia-Pacific Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2019-2031
8.3.4. Asia Pacific Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.4. Latin America
8.4.1. Latin America Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by Diagnosis, 2019-2031
8.4.2. Latin America Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2019-2031
8.4.3. Latin America Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2019-2031
8.4.4. Latin America Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by Diagnosis, 2019-2031
8.5.2. Middle East & Africa Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2019-2031
8.5.3. Middle East & Africa Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2019-2031
8.5.4. Middle East & Africa Cervical Spondylosis Diagnosis & Treatment Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Novartis AG
9.2.2. Merck & Co. Inc.
9.2.3. Bayer AG
9.2.4. Abbott
9.2.5. Ortho Bracing
9.2.6. Medtronic
9.2.7. Stryker Corporation
9.2.8. B. Braun Medical Ltd.
9.2.9. DJO, LLC
9.2.10. Aspen Medical Products, LLC
Cervical Spondylosis Diagnosis & Treatment Market By Diagnosis-
Cervical Spondylosis Diagnosis & Treatment Market By Product Type-
Cervical Spondylosis Diagnosis & Treatment Market By Distribution Channel-
Cervical Spondylosis Diagnosis & Treatment Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
